TBCH Q1 2026 Earnings EPS Misses Estimates Despite Strong Stock Rally Retractable Technologies Q3 2023 Earnings Loss Per Share of 014 Reported Stock Rises Amid Limited Disclosure CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up ARTL Q4 2025 Earnings Narrowing Loss Surprises but Revenue Remains Absent SVAQW Warrants Surge 968 as Momentum Builds Above Key Support Regentis Biomaterials RGNT Slides 97 as Stock Tests Support Near 185 Fractyl Health GUTS Holds Near Support After Minor Decline Futu Holdings FUTU Surges 17 Breaking Resistance or Nearing Overextension Dominion Energy Q1 2026 Earnings EPS Beats Estimates Amid Stable Utility Performance